{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T05:33:20Z","timestamp":1763876000483,"version":"3.45.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijrobp.2025.09.062","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T05:32:21Z","timestamp":1763875941000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Persistent Hypogonadism on Overall Survival After Androgen Deprivation Therapy in Localized Prostate Cancer Patients: Long-Term Prospective Data"],"prefix":"10.1016","author":[{"given":"Abdenour","family":"Nabid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Vigneault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9-Guy","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thu Van","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Bahary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vavassis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Bahoric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Andr\u00e9","family":"Brassard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Archambault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Redouane","family":"Bettahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Duclos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Souhami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.09.062_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2011.08.026","article-title":"Contemporary role of androgen deprivation therapy for prostate cancer","volume":"61","author":"Pagliarulo","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0002","unstructured":"National Comprehensive Cancer Network, NCCN guidelines version 1. 2025: prostate cancer. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf. Accessed February 28, 2025."},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0003","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/aja.2011.101","article-title":"Androgen deprivation therapy-associated vasomotor symptoms","volume":"14","author":"Jones","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0959-8049(00)00084-8","article-title":"Fatigue in patients with prostate cancer receiving hormone therapy","volume":"36","author":"Stone","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0006","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1464-410X.1997.00234.x","article-title":"Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade","volume":"79","author":"Strum","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0007","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2011.38.8850","article-title":"Sarcopenia during androgen-deprivation therapy for prostate cancer","volume":"30","author":"Smith","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0008","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0009","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.urolonc.2017.07.016","article-title":"Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis","volume":"35","author":"Nead","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/iju.13409","article-title":"Association between androgen deprivation therapy and anxiety among 78 000 patients with localised prostate cancer","volume":"24","author":"Dinh","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0011","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.juro.2006.08.113","article-title":"Penile length changes in men treated with androgen suppression plus radiation therapy for local or locally advanced prostate cancer","volume":"177","author":"Haliloglu","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0013","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijrobp.2017.02.019","article-title":"External beam radiation therapy or brachytherapy with or without short-course neoadjuvant androgen deprivation therapy: Results of a multicenter, prospective study of quality of life","volume":"98","author":"Gay","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0014","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/smrj.17","article-title":"Sexual Function in elderly men receiving androgen deprivation therapy (ADT)","volume":"2","author":"Fode","year":"2014","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000082","article-title":"Impact of hormonal therapies for treatment of hormone-dependent cancers (breast and prostate) on the cardiovascular system: Effects and modifications: A scientific statement from the American Heart Association","volume":"14","author":"Okwuosa","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0016","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: A claims-based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0017","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cncr.20388","article-title":"Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy","volume":"101","author":"Krupski","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0018","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0019","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1464-410X.2009.08483.x","article-title":"Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values","volume":"104","author":"Wadhwa","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/cen.12503","article-title":"Testosterone and mortality","volume":"81","author":"Muraleedharan","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0021","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical review: Endogenous testosterone and mortality in men: A systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0022","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-11-0447","article-title":"Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic study","volume":"165","author":"Corona","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0023","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2020.10.023","article-title":"Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial","volume":"143","author":"Nabid","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0024","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.eururo.2018.06.018","article-title":"Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized phase III trial","volume":"74","author":"Nabid","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0025","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: An endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0026","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1002\/cncr.35443","article-title":"Insulin resistance during androgen deprivation therapy in men with prostate cancer","volume":"130","author":"Basaria","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0027","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s001250050581","article-title":"Insulin resistance and coronary artery disease","volume":"39","author":"Bressler","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0028","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11136-024-03843-5","article-title":"Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: Long term data from a phase III trial","volume":"34","author":"Nabid","year":"2025","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002313","article-title":"Genetic determinants of serum testosterone concentrations in men","volume":"7","author":"Ohlsson","year":"2011","journal-title":"PLOS Genet"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and Goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0031","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijrobp.2025.01.022","article-title":"The benefit of short-term androgen deprivation therapy with radiation therapy for intermediate-risk prostate cancer","volume":"122","author":"Patel","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/JRYT3981","article-title":"The effects and safety of testosterone replacement therapy for men with hypogonadism: The TestES evidence synthesis and economic evaluation","volume":"28","author":"Cruickshank","year":"2024","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0033","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.sxmr.2020.12.003","article-title":"Testosterone therapy after prostate cancer treatment: A review of literature","volume":"9","author":"Natale","year":"2021","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0034","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0038","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jsxm.2016.04.068","article-title":"Challenges in testosterone measurement, data interpretation, and methodological appraisal of interventional trials","volume":"13","author":"Trost","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0039","doi-asserted-by":"crossref","first-page":"M163","DOI":"10.1093\/geronj\/43.6.M163","article-title":"Age-related alterations in the circadian rhythms of pulsatile luteinizing hormone and testosterone secretion in healthy men","volume":"43","author":"Tenover","year":"1988","journal-title":"J Gerontol"},{"key":"10.1016\/j.ijrobp.2025.09.062_bib0040","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/jcem-56-6-1278","article-title":"Loss of circadian rhythmicity in blood testosterone levels with aging in normal men","volume":"56","author":"Bremner","year":"1983","journal-title":"J Clin Endocrinol Metab"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625063357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625063357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T05:32:25Z","timestamp":1763875945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625063357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":37,"alternative-id":["S0360301625063357"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.062","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Persistent Hypogonadism on Overall Survival After Androgen Deprivation Therapy in Localized Prostate Cancer Patients: Long-Term Prospective Data","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.09.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}